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Descriptive Epidemiology of Colorectal Cancer in the
United States, 1998–2001, Utilizing Data from the
NPCR and SEER Programs
Supplement to Cancer

Colorectal Cancer in U.S. Adults Younger than
50 Years of Age, 1998--2001
Temeika L. Fairley, PhD1
Cheryll J. Cardinez, MSPH1
Jim Martin, PhD2
Linda Alley, PhD, RN1
Carol Friedman, DO1
Brenda Edwards, PhD3
Patricia Jamison, MPH1

BACKGROUND. Colorectal cancer (CRC) incidence rates are increasing among persons younger than 50 years of age, a population routinely not screened unless an
individual has a high risk of CRC. This population-based study focuses primarily
on describing the CRC burden for persons in this age group.

METHODS. The data used for this study were derived from the National Program
of Cancer Registries (NPCR) and Surveillance, Epidemiology, and End Results
(SEER) surveillance systems. Age-adjusted incidence rates, rate ratios, and their
corresponding 95% confidence intervals were calculated.
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RESULTS. CRC is ranked among the top 10 cancers occurring in males and
females aged 20–49 years regardless of race. Persons younger than 50 years were
more likely to present with less localized and more distant disease than do older
adults. Among younger adults, age-adjusted incidence rates for poorly differen-
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tiated cancers were twice as high as rates for well-differentiated cancers. Incidence rates for poorly differentiated cancers were 60% higher than that for well-
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differentiated cancers diagnosed in older adults. Rates were significantly higher

Cancer Surveillance Research Program, Division
of Cancer Control and Population Sciences,
National Cancer Institute, Bethesda, Maryland.

for blacks and significantly lower for Asians/Pacific Islanders when compared
with that for whites for the most demographic and tumor characteristics examined.

CONCLUSIONS. This study confirms the findings of previous population-based
studies suggesting that younger patients present with more advanced disease
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than do older patients. This study also identifies racial and ethnic disparities in
CRC incidence in this population. These findings suggest the need for additional
studies to understand the behavior and etiology of CRC in blacks. Cancer
2006;107(5 Suppl):1153–61.  2006 American Cancer Society.
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I

n 2002, there were 139,534 new cases of colorectal cancer (CRC)
diagnosed in the United States, based on 93% of the U.S. population.1 Of these cases, 127,743 (91.5%) occurred in persons older than
50 years of age, and 11,791 (8.5%) occurred in persons younger than
50 years (P. Wingo, January 13, 2006, personal communication). A
reported 2% to 9% of all CRC cases diagnosed are in persons
younger than 50 years.2,3 Previous research has shown increasing
CRC incidence rates among persons younger than 50 years,4–6 a
population not routinely screened unless individuals have a high
risk of CRC (i.e., those with family history or other predisposing
conditions).7–9
Several clinic- and hospital-based investigations among persons
younger than 50 years have reported that those in this age group

ª 2006 American Cancer Society
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present with more advanced stages of disease than
do older adults, but discrepancies exist concerning
the prognosis for survival among younger patients.2,5,10,11 Population-based descriptive studies
suggest that persons younger than 50 years present
with more advanced disease and have fewer localized
tumors than do older adults6,10,12,13 and that the incidence rates and the percentage of proximal or rightsided cancers are higher for blacks than for
whites.14,15 Recent population-based studies have
also documented that survival was not significantly
worse for persons younger than 50 years than for
older adults.2
Previous studies of CRC in individuals younger
than 50 years had relatively small sample sizes and
focused primarily on persons younger than 40 years.
Advances in cancer surveillance, such as expansions
in geographic coverage, allow description of CRC
incidence in this population. This population-based
study focuses on describing the CRC burden for persons younger than 50 years by sociodemographics
and tumor characteristics such as stage, tumor grade,
and anatomic subsite. Inclusion of cases among individuals aged 40–49 years allows us to describe the
CRC burden for individuals nearest the recommended CRC screening age. Although the main
emphasis of this study is CRC in persons younger
than 50 years of age, we have included some data for
older adults for comparison.

METHODS
Data
The 1998–2001 combined National Program of Cancer Registries (NPCR) and Surveillance, Epidemiology, and End Results (SEER) data used for this
analysis have been described elsewhere.16 Briefly, 39
statewide registries and the metropolitan Atlanta and
District of Columbia central cancer registries were
included in the data set, which covers 88% of the
U.S. population. The entire dataset comprised a total
of 542,149 patients with invasive colorectal cancer
(CRC), of whom 42,017 were younger than 50 years.

Description of Variables
The sociodemographic variables included the following: age (0–19 years, 20–39 years, 40–49 years, 50
years), sex, race (white, black, Asians/Pacific Islanders [API], and other races combined [American
Indians/Alaska Natives, other, and unknown]), ethnicity (Hispanic, non-Hispanic), and U.S. Census region (Northeast, Midwest, South, and West). For race,

American Indians/Alaska Natives were combined
with other and unknown because of the small overall
percentages. The tumor characteristics included the
following: anatomical subsite (proximal colon [C18.0C18.5], distal colon [C18.6-C18.7], colon, NOS [C18.8C18.9, C26.0], and rectum [C19.9, C20.9])17; SEER
summary stage (localized, regional, distant, and
unstaged)18; and grade at diagnosis (well differentiated, moderately differentiated, poorly differentiated,
undifferentiated, and unknown). SEER summary stage
data were submitted for only 3 regions in California
(San Francisco-Oakland, San Jose-Monterrey, and Los
Angeles). Thus, analyses using the SEER summary
stage variable include 39,560 patients younger than 50
years and 472,294 patients aged 50 years or older.
Analyses for grade were limited to microscopically
confirmed cases only and include 41,467 patients
younger than 50 years and 481,163 patients aged 50
years or older.

Analysis
All analyses were conducted in SEER*Stat version
6.1.4.19 Rates were age-adjusted to the 2000 U.S.
standard population by 5-year age groups; corresponding 95% confidence intervals were based on
the gamma method.20 Rate ratios and corresponding
95% confidence intervals were calculated and used
for rate comparisons. A significance level of P ¼ 0.05
was used for these analyses. The top 10 cancers by
race, sex, and 3 age groups (0–19, 20–39, and 40–49
years) were ranked on the basis of 27 cancer sites to
assess the burden of CRC relative to other cancers
common in this age group.

RESULTS
Our results indicate that CRC ranked among the top
4 cancers occurring in males and females aged 40–49
years, regardless of race (Fig. 1), and it was the most
frequently diagnosed cancer among 40 to 49-year-old
API males (data not shown). Among 20 to 39-yearolds, CRC ranked among the top 10 cancers (Fig. 1)
and was the second most frequently diagnosed cancer among black and API males (data not shown).
CRC was not ranked among the top 10 cancers diagnosed in males and females aged 0–19 years (data
not shown).
A majority (74.3%) of cases was diagnosed
in adults aged 40–49 years; 25.1% were diagnosed in
persons aged 20–39 years; 0.5% were diagnosed in
those younger than 20 years of age. The percentages
of persons younger than 50 years and of persons
aged 50 or older were similar for males and females
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FIGURE 1. Top 10 invasive cancer sites by age and sex, adults 20--49 years of age, United States, 1998--2001. Rates are per 100,000 and age adjusted to
the 2000 U.S. population standard. Data are from cancer registries that participate in the NPCR and/or the SEER Program: Alabama, Alaska, Arizona, Atlanta,
California, Colorado, Connecticut, District of Columbia, Florida, Hawaii, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maine, Massachusetts, Michigan, Minnesota, Missouri, Montana, Nebraska, New Jersey, New Mexico, New York, North Carolina, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South
Carolina, Texas, Utah, Vermont, Washington, West Virginia, Wisconsin, Wyoming. These registries had high-quality data for the period 1998--2001 and collectively cover 88% of the U.S. population.

(Table 1). Persons younger than 50 years were more
likely than older adults to be black (14.3%), API
(3.9%), and Hispanic (9.4%). There were more rectal
cancers diagnosed among persons younger than
50 years of age than among older adults (37% vs.
26.2%). However, proximal colon cancers were diagnosed less frequently in persons younger than 50 years
than among older adults (32.1% vs. 42.6%). Ageadjusted incidence rates were highest for rectal cancers diagnosed in persons younger than 50 years and
for proximal cancers diagnosed in persons older than
50. Compared with older adults, persons younger
than 50 years presented with less localized (29.7% vs.
35.1%) and more distant (21.9% vs. 16.0%) disease.
The younger group also had fewer well-differentiated
(8.8% vs. 10.0%) and more poorly differentiated
(18.4% vs. 16.3%) tumors. In younger adults, ageadjusted incidence rates for poorly differentiated cancers were twice as high as rates for well-differentiated
cancers; in older adults, incidence rates for poorly
differentiated cancers were 60% higher than that
for well-differentiated cancers. Rates differed by U.S.
Census region between the 2 age groups. The average
annual age-adjusted incidence rate among younger
persons was highest for cases diagnosed in the South,
followed by the Northeast, Midwest, and West. Among

older persons, the highest rates were reported for
the Northeast followed by the Midwest, South, and
West.
Age-adjusted incidence rates were significantly
higher for blacks and significantly lower for API than
for whites for most demographic and tumor characteristics examined (Table 2). Rates for all racial populations were similar among persons aged 0–19 and
20–39 years, but among adults aged 40–49 years,
rates for blacks were almost 40% higher than that for
whites and almost 60% higher than that for API. These
differences were observed primarily in adults aged 45–
49 years for both males and females (Fig. 2). Blacks
(38.2%) had more proximal cancers than did whites
(31.4%) or APIs (26.1%; Fig. 3). The rate of proximal
colon cancer in blacks was 61% higher than that in
whites and 200% higher than that in APIs. API had
more rectal cancers (42.7%) than did whites (38.0%)
or blacks (29.6%), but the rates of rectal cancer did
not differ appreciably by race. The rates for proximal
colon and rectal cancers were significantly higher than
that for distal colon cancers for all racial groups (Table
2). Examination of stage by race among persons
younger than 50 years revealed that blacks presented
with more distant and unstaged disease and less localized disease than did whites and APIs (Fig. 4).
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TABLE 1
Demographic and Tumor Characteristics for Invasive Colon and Rectum Cancers by Age Group, United States, 1998–2001*
0–49 Years

N
Total
Age (yrs)
0–19
20–39
40–49
Sex
Male
Female
Race
White
Black
Asian/Pacific Islander
Other (AI/AN, other, unknown)
Ethnicity§
Non-Hispanic
Hispanic
U.S. Census Region
Northeast
Midwest
South
West
Tumor Location
Proximal colon (C18.0–C18.5)
Distal colon (C18.6-C18.7)
Colon, NOS (C18.8-C18.9, C26.0)
Rectum (C19.9, C20.9)
SEER Summary Stage|
Localized
Regional
Distant
Unstaged
Grade}
Well differentiated; Grade I
Moderately differentiated; Grade II
Poorly differentiated; Grade III
Undifferentiated; Grade IV
Unknown

%

Age-adjusted
ratey (95% CI)

42,017

>50 Years
Rate ratio
(95% CI)

6.0 (5.9–6.0)

N

%

500,132

Age-adjusted ratey
(95% CI)

Rate ratio
(95% CI)

185.6 (185.1–186.1)

225
10,554
31,238

0.5
25.1
74.3

0.1 (0.1–0.1)
3.7 (3.6–3.8)
21.0 (20.8–21.2)

22,164
19,853

52.8
47.2

6.3 (6.2–6.4)
5.6 (5.5–5.7)

1.1 (1.1–1.2)
Referent

251,031
249,101

50.2
49.8

222.6 (221.7–223.5)
158.3 (157.7–158.9)

1.4 (1.4–1.4)
Referent

33,464
6024
1618
911

79.6
14.3
3.9
2.2

5.7 (5.6–5.8)
7.6 (7.4–7.8)
5.0 (4.8–5.3)

Referent
1.3 (1.3–1.4)
0.9 (0.8–0.9)

441,395
42,290
10,156
6291

88.3
8.5
2.0
1.3

184.3 (183.7–184.8)
198.1 (196.2–200.1)
134.7 (132.0–137.5)

Referent
1.1 (1.1–1.1)
0.7 (0.7–0.7)

38,078
3937

90.6
9.4

6.1 (6.0–6.2)
4.9 (4.7–5.0)

Referent
0.8 (0.8–0.8)

477,212
22,892

9376
10,671
13,224
8746

22.3
25.4
31.5
20.8

6.2 (6.0–6.3)
5.9 (5.8–6.0)
6.7 (6.6–6.8)
5.0 (4.9–5.1)

Referent
1.0 (0.9–1.0)
1.1 (1.1–1.1)
0.8 (0.8–0.8)

13,486
10,986
2005
15,540

32.1
26.1
4.8
37.0

1.9 (1.9–1.9)
1.6 (1.5–1.6)
0.3 (0.3–0.3)
2.2 (2.2–2.2)

11,757
16,016
8644
3143

29.7
40.5
21.9
7.9

3634
22,699
7649
394
7091

8.8
54.7
18.4
1.0
17.1

{

{

{

{

95.4
4.6

188.0 (187.5–188.6)
145.8 (143.9–147.8)

Referent
0.8 (0.8–0.8)

129,788
136,318
136,644
97,382

26.0
27.3
27.3
19.5

207.4 (206.3–208.5)
193.8 (192.8–194.8)
176.6 (175.6–177.5)
164.7 (163.6–165.7)

Referent
0.9 (0.9–0.9)
0.9 (0.8–0.9)
0.8 (0.8–0.8)

1.2 (1.2–1.3)
Referent
0.2 (0.2–0.2)
1.4 (1.4–1.4)

212,893
125,108
31,001
131,130

42.6
25.0
6.2
26.2

79.0 (78.6–79.3)
46.4 (46.2–46.7)
11.5 (11.4–11.6)
48.7 (48.4–49.0)

1.7 (1.7–1.7)
Referent
0.2 (0.2–0.3)
1.0 (1.0–1.1)

1.8 (1.8–1.8)
2.4 (2.4–2.5)
1.3 (1.3–1.3)
0.5 (0.5–0.5)

Referent
1.4 (1.3–1.4)
0.7 (0.7–0.8)
0.3 (0.3–0.3)

165,803
183,092
75,369
48,030

35.1
38.8
16.0
10.2

65.7 (65.4–66.0)
72.6 (72.2–72.9)
29.9 (29.7–30.1)
19.0 (18.9–19.2)

Referent
1.1 (1.1–1.1)
0.5 (0.5–0.5)
0.3 (0.3–0.3)

0.5 (0.5–0.5)
3.2 (3.2–3.3)
1.1 (1.1–1.1)
0.1 (0.1–0.1)
1.0 (1.0–1.0)

Referent
6.3 (6.0–6.5)
2.1 (2.0–2.2)
0.1 (0.1–0.1)
1.9 (1.9–2.0)

48,252
291,248
78,264
3304
60,095

10.0
60.5
16.3
0.7
12.5

17.9 (17.7–18.1)
108.1 (107.7–108.5)
29.0 (28.8–29.2)
1.2 (1.2–1.3)
22.3 (22.1–22.5)

Referent
6.0 (6.0–6.1)
1.6 (1.6–1.6)
0.1 (0.1–0.1)
1.2 (1.2 –1.3)

* Data are from population-based cancer registries that participate in the National Program of Cancer Registries (NPCR) and/or the Surveillance Epidemiology and End Results (SEER) Program and meet highquality data criteria: Alabama, Alaska, Arizona, California, Colorado, Connecticut, District of Columbia, Florida, Metro Atlanta (Georgia), Hawaii, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maine,
Massachusetts, Michigan, Minnesota, Missouri, Montana, Nebraska, New Jersey, New Mexico, New York, North Carolina, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, Texas, Utah, Vermont, Washington, West Virginia, Wisconsin, Wyoming. These registries cover approximately 88% of the U.S. population.
y
Rates are per 100,000 and age-adjusted to the 2000 U.S. population standard.
{
Rates were not calculated because population denominator was not available.
§
Ethnicity is reported using the NAACCR Hispanic Identification Algorithm for NPCR registries and Hispanic/Spanish Origin (NAACCR no. 190) for SEER registries. Unknown ethnicity was not included since
there were fewer than 50 in the entire dataset.
|
Some regions in California did not contribute SEER summary stage data. The sample sizes are 39,560 for 0–49 years and 472,294 for >50 years.
}
Grade analyses were limited to microscopically confirmed cases. The sample sizes are 41,467 for 0--49 years and 481,163 for >50 years.

DISCUSSION
To our knowledge, this is the largest populationbased study of CRC among persons younger than 50
years of age and is the first to describe the burden of
CRC in 40 to 49-year-olds. This large nationwide

study revealed that CRC is one of the 10 most commonly diagnosed cancers among men and women
aged 20–49 years. Such findings have not been previously reported for the United States. However, a
recent study that assessed the burden of cancer in
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TABLE 2
Demographics and Tumor Characteristics for Invasive Colon and Rectum Cancers for Persons Aged 0–49 Years by Race, United States, 1998–2001*
White
Age-adjusted ratey
(95% CI)
Total
Age
0–19 years
20–39 years
40–49 years
Sex
Male
Female
Region
Northeast
Midwest
South
West
Tumor location
Proximal colon (C18.0-C18.5)
Distal colon (C18.6-C18.7)
Colon, NOS (C18.8-C18.9, C26.0)
Rectum (C19.9, C20.9)
SEER Summary Stage§
Localized
Regional
Distant
Unstaged
Grade|
Well differentiated; Grade I
Moderately differentiated; Grade II
Poorly differentiated; Grade III
Undifferentiated; Grade IV
Unknown

Black
Rate ratio
(95% CI)

Age-adjusted ratey
(95% CI)

5.7 (5.6–5.8)

7.6 (7.4–7.8)

0.1 (0.1–0.1)
3.6 (3.5–3.7)
20.1 (19.8–20.3)

0.1 (0.0–0.1)
4.4 (4.2–4.7)
27.5 (26.7–28.3)

Asian/Pacific Islander
Rate ratio
(95% CI)

Age-adjusted ratey
(95% CI)

Rate ratio
(95% CI)

5.0 (4.8–5.3)
{

3.2 (2.9–3.5)
17.5 (16.5–18.5)

6.1 (6–6.2)
5.3 (5.2–5.4)

1.1 (1.1–1.2)
Referent

8.0 (7.8–8.3)
7.2 (7.0–7.5)

1.1 (1.1–1.2)
Referent

5.3 (5.0–5.7)
4.7 (4.4–5.0)

1.1 (1.0–1.3)
Referent

6.0 (5.9–6.1)
5.6 (5.5–5.8)
6.4 (6.2–6.5)
4.8 (4.7–4.9)

Referent
0.9 (0.9–1.0)
1.1 (1.0–1.1)
0.8 (0.8–0.8)

6.8 (6.4–7.2)
7.6 (7.2–8.0)
8.3 (8.0–8.6)
6.5 (5.9–7.0)

Referent
1.1 (1.0–1.2)
1.2 (1.1–1.3)
0.9 (0.9–1.0)

4.6 (4.1–5.1)
4.2 (3.6–5.0)
4.1 (3.5–4.7)
5.5 (5.2–5.9)

Referent
0.9 (0.8–1.1)
0.9 (0.7–1.1)
1.2 (1.1–1.4)

1.8 (1.8–1.8)
1.5 (1.5–1.5)
0.3 (0.2–0.3)
2.2 (2.1–2.2)

1.2 (1.2–1.2)
Referent
0.2 (0.2–0.2)
1.5 (1.4–1.5)

2.9 (2.8–3.0)
1.9 (1.8–2.0)
0.5 (0.5–0.6)
2.2 (2.1–2.4)

1.5 (1.4–1.6)
Referent
0.3 (0.2–0.3)
1.2 (1.1–1.2)

1.3 (1.2–1.4)
1.4 (1.3–1.5)
0.2 (0.1–0.2)
2.1 (2.0–2.3)

0.9 (0.8–1.1)
Referent
0.1 (0.1–0.2)
1.5 (1.3–1.7)

1.7 (1.7–1.8)
2.3 (2.3–2.4)
1.2 (1.2–1.3)
0.4 (0.4–0.5)

Referent
1.3 (1.3–1.4)
0.7 (0.7–0.7)
0.2 (0.2–0.3)

2.0 (1.9–2.1)
3.0 (2.9–3.2)
1.9 (1.8–2.0)
0.7 (0.7–0.8)

Referent
1.5 (1.4–1.6)
1.0 (0.9–1.1)
0.4 (0.3–0.4)

1.6 (1.5–1.8)
2.2 (2.0–2.4)
1.1 (0.9–1.2)
0.3 (0.2–0.3)

Referent
1.4 (1.2–1.6)
0.7 (0.6–0.8)
0.2 (0.1–0.2)

0.5 (0.5–0.5)
3.1 (3.0–3.1)
1.1 (1.0–1.1)
0.1 (0.1–0.1)
0.9 (0.9–0.9)

Referent
6.2 (6.0–6.5)
2.1 (2.0–2.2)
0.1 (0.1–0.1)
1.9 (1.8–1.9)

0.6 (0.6–0.7)
4.1 (3.9–4.2)
1.2 (1.1–1.3)
0.1 (0.0–0.1)
1.5 (1.4–1.6)

Referent
6.3 (5.8–7.0)
1.9 (1.7–2.1)
0.1 (0.1–0.1)
2.3 (2.1– 2.6)

0.4 (0.3–0.4)
2.8 (2.6–3.0)
1.0 (0.9–1.1)

Referent
7.8 (6.4–9.5)
2.9 (2.3–3.6)

{

0.8 (0.7–0.9)

}

2.2 (1.7–2.7)

* Data are from population-based cancer registries that participate in the National Program of Cancer Registries (NPCR) and/or the Surveillance Epidemiology and End Results (SEER) Program and meet highquality data criteria (see Table 1 footnote for list of registries). These registries cover approximately 88% of the U.S. population.
y
Rates are per 100,000 and age-adjusted to the 2000 U.S. population standard.
{
Rates were suppressed if fewer than 16 cases were reported.
§
Some regions in California did not contribute SEER summary stage data. The sample size is 39,560 for 0–49 years.
|
Grade analyses were limited to microscopically confirmed cases. The sample size is 41,467 for 0–49 years.
}
Rate ratio could not be calculated.

Canadian young adults aged 20–44 years reported
similar findings.21 Seventy-four percent of the 42,017
cases diagnosed among adults younger than 50 years
occurred among persons aged 40–49. Patterns for
CRC rates by sex and ethnicity were similar for persons younger than 50 years and older adults. This
study confirms findings of earlier research showing
that persons younger than 50 years of age present
with fewer localized and more poorly differentiated
tumors than do older adults.
In our study, almost 8% of all CRC cases occurred in persons younger than 50 years of age; 2%
were diagnosed in persons younger than 40, and 6%

among those aged 40–49 years. These findings are
consistent with previous population-based studies of
this age group. In 1991, Griffin reported that 3.1% of
all CRC cases occurred among individuals younger
than 40 years old.10 O’Connell reported a slightly
smaller proportion of CRC among the same population over a 20-year period (2.1%).6 Studies conducted outside of the United States showed that in
France 3.1% of all CRC cases occurred in persons
younger than 45 years12; in Australia approximately
5% of all CRC cases occurred in persons younger
than 45 years22; and in Denmark 2.5% of all CRC
cases occurred in persons younger than 40 years.23
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FIGURE 2. Invasive colon and rectum cancer rates by race and sex, adults
40--49 years of age, United States, 1998--2001. Rates are per 100,000 and
age adjusted to the 2000 U.S. population standard. Data are from population-based cancer registries that participate in the NPCR and/or the SEER
Program and meet high-quality data criteria: Alabama, Alaska, Arizona, California, Colorado, Connecticut, District of Columbia, Florida, Metro Atlanta
(Georgia), Hawaii, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana,
Maine, Massachusetts, Michigan, Minnesota, Missouri, Montana, Nebraska,
New Jersey, New Mexico, New York, North Carolina, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, Texas, Utah, Vermont,
Washington, West Virginia, Wisconsin, Wyoming. These registries cover
approximately 88% of the U.S. population.

FIGURE 3. Percentage distribution of tumor location for invasive colon and
rectum cancers by race, persons from birth to 49 years of age, United
States, 1998--2001. Data are from population-based cancer registries that
participate in the NPCR and/or the SEER Program and meet high-quality data
criteria: Alabama, Alaska, Arizona, California, Colorado, Connecticut, District
of Columbia, Florida, Metro Atlanta (Georgia), Hawaii, Idaho, Illinois, Indiana,
Iowa, Kansas, Kentucky, Louisiana, Maine, Massachusetts, Michigan, Minnesota, Missouri, Montana, Nebraska, New Jersey, New Mexico, New York,
North Carolina, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South
Carolina, Texas, Utah, Vermont, Washington, West Virginia, Wisconsin, Wyoming. These registries cover approximately 88% of the U.S. population. NOS.

FIGURE 4. Percentage distribution of SEER Summary Stage for invasive
colon and rectum cancers by race, persons from birth to 49 years of age,
United States, 1998--2001. Data are from population-based cancer registries
that participate in the NPCR and/or the SEER Program and meet high-quality
data criteria: Alabama, Alaska, Arizona, California, Colorado, Connecticut,
District of Columbia, Florida, Metro Atlanta (Georgia), Hawaii, Idaho, Illinois,
Indiana, Iowa, Kansas, Kentucky, Louisiana, Maine, Massachusetts, Michigan,
Minnesota, Missouri, Montana, Nebraska, New Jersey, New Mexico, New
York, North Carolina, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island,
South Carolina, Texas, Utah, Vermont, Washington, West Virginia, Wisconsin,
Wyoming. These registries cover approximately 88% of the U.S. population.

Overall, the age-adjusted incidence rates reported in our study are similar to those of previous
population-based studies. All races combined, increasing age-adjusted incidence rates with increasing
age and higher rates for males than for females were
documented, findings consistent with numerous
published reports.10,13,15,24–26 We also found that
younger people present with later stage disease and
poorer tumor grades at diagnosis.27 No definitive
explanations for these differences have been determined. It is possible, however, that younger patients
present with later disease because they are not
screened6 or are at increased risk because of a higher
prevalence of conditions predisposing them to CRC.
To determine the impact of these explanations on
stage of disease and tumor grade at diagnosis, we
need to collect specific information on risk factors
for developing CRC, such as having a family history of
CRC, colorectal polyps, chronic inflammatory bowel
disease, and history of genetic abnormalities such as
familial adenomatous polyposis (FAP) or hereditary
nonpolyposis colorectal cancer (HNPCC). Previous
studies have documented that approximately 8% of
young colorectal patients have FAP,12 and approximately 10% of cases occur in families with HNPCC.28
In this study, almost 75% of the persons with CRC
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younger than 50 years were 40–49 years old. Many of
these individuals may have had an increased risk for
developing CRC because conditions like HNPCC
usually appear in this age group.29
Studies geared toward persons younger than
50 years of age may be essential to understanding the
potential etiologic differences in this age group. For
example, population-based case–control studies, such
as the Women’s CARE study,30 could be designed to
examine risk factors for CRC in a young population.
The National Cancer Institute established the Cancer
Family Registries (CFR) to facilitate both populationbased and clinic-based interdisciplinary studies in the
genetic epidemiology of cancer and to provide a flexible, comprehensive, and collaborative research infrastructure. Several CFR programs systematically collect
family history information, epidemiologic and clinical
data, and related biological specimens from individuals with CRC and their families.31
Differences in stage and grade of disease among
younger cases may also be attributable to delays in
diagnosis caused in part by delays in patient presentation, lack of access to medical care, or misdiagnosis by the physician. Studies have reported delays in
presentation as long as 9 years, mostly due to patient
factors such as lack of knowledge about CRC symptoms, particularly among persons younger than
50 years.2,11,32,33 Other studies have identified delays
due to physician misdiagnosis.34,35 Both instances
emphasize the need for increased awareness about
the incidence of CRC in persons younger than
50 years. Additional patient and provider education
on the CRC symptoms and signs, given to patients
before the recommended screening age of 50 years,
may decrease the delays in diagnosis and subsequently positively affect the stage of disease at diagnosis.
Current efforts in CRC prevention focus primarily
on screening and the removal of any precancerous
polyps or abnormal growths detected in individuals
aged 50 years and older. Because persons younger
than 50 years are less likely to be screened for CRC
than are older adults, some attention should be given
to preventing disease in young adults by addressing
modifiable risk factors such as smoking, alcohol consumption, physical inactivity, excess body weight,
and poor diet.36 Studies have shown that increased
physical activity and maintaining a healthy weight
can decrease the risk for CRC.37 However, excess
body weight and physical inactivity account for only
approximately one fourth to one third of cancers of
the colon.38 Further study is needed to understand
fully the effect of these and other risk factors on persons younger than 50 years.
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Our investigation of the differences in the occurrence of cancer by geographic area among persons
younger than 50 years and among older adults
revealed that race may have influenced our results.
In the younger age group, incidence rates were
higher for blacks than that for any other population.
When we examined the incidence rates within Census regions by race for this age group, the rates for
blacks were higher than that for whites in all regions,
with the highest rates for blacks being in the South.
Thus, among those younger than 50 years, the incidence rates for blacks affect the pattern of incidence
rates by Census region described in this study. This
pattern, however, is not consistent with that of the
older population. The pattern of incidence rates by
Census region appears to follow the rates for whites
in each region, which were highest in the Northeast,
followed by the Midwest, South, and West.
Previous studies reported that blacks present
with CRC at a younger age than do whites13 and
with more late-stage cancers than do whites and
API.10,13,15 Our results are consistent with those findings. We also found that blacks have higher rates of
proximal cancers than do whites10 or API.25 Recent
recommendations were made to lower the CRC
screening age for blacks from 50–45 years and to
require the use of colonoscopy as the first-line
screening procedure for blacks.39 CRC screening
using flexible sigmoidoscopies and colonoscopies has
been consistently associated with lower CRC incidence and mortality.40 Colonoscopy is the most sensitive and specific test for detecting cancer and large
polyps; however, there are higher risks associated
with this test than with other screening tests for
CRC.41 It is not certain whether the potential added
benefits of colonoscopy relative to screening alternatives are large enough to justify the added risks and
inconvenience to all patients.41 More research is
needed to determine whether current screening recommendations need to be modified for blacks and
what might be the impact of such modifications on
mortality and survival in this population. Current
population-based studies should be considered by
the U.S. Preventive Task Force and the American
Cancer Society when considering the re-examination
of the recommended screening age of 50 years for
those at average risk, especially for blacks.
We note several potential limitations of this
study. Although cancer incidence data used in this
study were from population-based cancer registries
in the United States that use standard codes for race,
the collection of race information has not been standardized. Thus, some misclassification is expected
regarding race, particularly for API and Hispanics.
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Second, population coverage for the South is about
70%, and so, rates provided for this region may not
be generalizable to the entire South. It will be important to re-examine these estimates as population
coverage for this region increases. Third, we documented a substantial number of tumors that were
unstaged or had an unknown grade. The impact of
these findings on our study is not clear because the
percentages for unknown stage and grade are higher
among blacks than among whites and APIs. Finally,
because of changes in staging systems/protocols for
all registries, our analysis included data staged using
both SEER Summary Stage 1977 for 1998–2000 data
and SEER Summary Stage 2000 for 2001 data. The
extent of the effect of these changes on our results is
likely negligible for CRC.42
In summary, we have used population-based
data to describe the nationwide burden of CRC
among persons younger than 50 years of age in the
United States. Our study demonstrates that CRC is
one of the most frequently diagnosed cancers in
young adults, particularly in 40 to 49-year-olds. This
important finding has not been previously reported
in the United States. We also confirmed the findings
of previous population-based studies suggesting that
younger patients present with more aggressive disease in terms of stage and grade at presentation than
do older patients. This population may be diagnosed
at later stages and have a worse disease prognosis;
therefore, emphasis should also be placed on provider and patient education about disease symptoms
as well as further investigation of risk factors for
developing CRC in this age group. Also consistent
with earlier studies, our study identified racial and
ethnic disparities in CRC incidence and stage at diagnosis in this population. Higher proportions of proximal cancers among blacks than in other racial
populations, coupled with more late-stage disease in
this population, suggest the need for additional studies to understand the behavior and etiology of this
disease in blacks. Such studies may be necessary to
support or refute current recommendations to modify the CRC screening guidelines in blacks.39
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